LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease

Molecular and Cellular Neuroscience

Volumn 24, Issue 4, 2003, Pages 1170-1179

  Harrison, S M ^a   Reavill, C ^a   Brown, G ^a   Brown, J T ^a   Cluderay, J E ^a   Crook, B ^a   Davies, C H ^a   Dawson, L A ^a   Grau, E ^a   Heidbreder, C ^a   Hemmati, P ^a   Hervieu, G ^a   Howarth, A ^a   Hughes, Z A ^a   Hunter, A J ^a   Latcham, J ^a   Pickering, S ^a   Pugh, P ^a   Rogers, D C ^a   Shilliam, C S ^a   Maycox, P R ^a   more..

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; LYSOPHOSPHATIDIC ACID 1 RECEPTOR; MEMBRANE RECEPTOR; NEUROTRANSMITTER; SEROTONIN; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FEMALE; GENE DELETION; GENE LOCUS; HOMOZYGOSITY; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; ANIMAL; BRAIN; C57BL MOUSE; COMPARATIVE STUDY; GENETICS; METABOLISM; MOUSE MUTANT; PHENOTYPE; PHYSIOLOGY; REACTION TIME; STARTLE REFLEX;

ANIMALS; BRAIN; FEMALE; MALE; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; REACTION TIME; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; STARTLE REACTION;

EID: 0345863390     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.09.001     Document Type: Article

References (41)

1. Allard J., Barron S., Diaz J., Lubetzki C., Zalc B., Schwartz J.-C., Sokoloff P.A. A rat G protein-coupled receptor selectively expressed in myelin-forming cells. Eur. J. Neurosci. 10:1998;1045-1053.
2. An S., Dickens M.A., Bleu T., Hallmark O.G., Goetzl E.J. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun. 231:1997;619-622.
3. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen. Psychiatry. 33:1976;1193-1197.
4. Bickerdike M.J., Wright I.K., Marsden C.A. Social isolation attenuates rat forebrain 5-HT release induced by KCl stimulation and exposure to a novel environment. Behav. Pharmacol. 4:1993;231-236.
5. Bilder R.M. Schizophrenia as a neurodevelopmental disorder. Curr. Opin. Psychiatry. 14:2001;9-15.
6. Braff D.L., Grillon C., Geyer M.A. Sensorimotor gating and schizophrenia. Arch. Gen. Psychiatry. 49:1992;206-215.
7. Callicott J.H., Bertolino A., Egan M.F., Mattay V.S., Langheim F.J., Weinberger D.R. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am. J. Psychiatry. 157:2000;1646-1651.
8. Contos J.J., Fukushima N., Weiner J.A., Kaushal D., Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA. 97:2000;13384-13389.
9. Davies C.H., Davies S.N., Collingridge G.L. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J. Physiol. 424:1990;513-531.
10. Dawson L.A., Stow J.M., Palmer A.M. Improved temporal resolution of microdialysis measurement of glutamate and aspartate using capillary electrophoresis with laser induced fluorescence detection. J. Chromatogr. B. 694:1997;455-460.
11. Depue R.A., Spoont M.R. Conceptualizing a serotonin trait. Ann. NY Acad. Sci. 487:1986;47-62.
12. Dursun S.M., Szemis A., Andrews H., Whitaker P., Reveley M.A. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia a cross-sectional study . J. Psychiatry Neurosci. 25:2000;347-352.
13. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsey A.A., Henn F.A. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr. Res. 41:2000;389-395.
14. Fletcher P.J., Phil D., Selhi Z.F., Azampanah A., Sills T.L. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine . Neuropsychopharmacology. 24:2001;399-409.
15. a1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA. 95:1998;6151-6156.
16. Fukushima N., Weiner J.A., Chun J. Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev. Biol. 228:2000;6-18.
17. Gogos J.A., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., Nadler J.V., Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21:1999;434-439.
18. Handford E.J., Smith D., Hewson L., McAllister G., Beer M. Edg2 receptor distribution in adult rat brain. Neuroreport. 12:2001;757-760.
19. Harrison D.C., Davis R.P., Bond B.C., Campbell C.A., James M.F., Parsons A.A., Philpott K.L. Caspase mRNA expression in a rat model of focal cerebral ischemia. Mol. Brain. Res. 89:2001;133-146.
20. Harrison P.J. The neuropathology of schizophrenia a critical review of the data and their interpretation . Brain. 122:1999;593-624.
21. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 11:2001;508-519.
22. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1996;1071-1083.
23. Heidbreder C.A., Weiss I., Domeney A., Pryce C., Homberg J., Hedou G., Feldon J., Moran M.C., Nelson P. Behavioral, neurochemical, and endocrinological characterization of the early social isolation syndrome. Neuroscience. 100:2000;749-768.
24. Hertel P., Nomikos G., Iurlo M., Svensson T.H. Risperidone regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain . Psychopharmacology. 124:1996;74-86.
25. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the Orexin-1 receptor in the rat brain and spinal cord. Neuroscience. 103:2001;777-797.
26. Kehne J.H., Padich R.A., McCloskey T.C., Taylor V.L., Schmidt C.J. 5-HT modulation of auditory and visual sensorimotor gating I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats . Psychopharmacology. 124:1996;95-106.
27. Kozlovsky N., Belmaker R.H., Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 12:2002;13-25.
28. McIntyre T.M., Ponstler A.V., Silva A.R., St. Hilaire A., Xu Y., Hinshaw J.C., et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA) LPA is a transcellular PPARγ agonist . Proc. Natl. Acad. Sci. USA. 100:2003;131-136.
29. Murphy K.C. Schizophrenia and velo-cardio-facial syndrome. Lancet. 359:2002;426-430.
30. 9/GPR23 as a novel protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278:2003;25600-25606.
31. Robbins T.W., Jones G.H., Wilkinson L.S. Behavioural and neurochemical effects of early social deprivation in the rat. J. Psychopharmacol. 10:1996;39-47.
32. Rogers D.C., Fisher E.M.C., Brown S.D.M., Peters J., Hunter A.J., Martin J.E. 'SHIRPA' - a comprehensive behavioural and functional analysis of mouse phenotype. Mamm. Genome. 8:1997;711-713.
33. Rydin E., Schalling D., Asberg M. Rorschach ratings in depressed patients and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Psychol. Res. 7:1982;229-243.
34. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71:2002;877-892.
35. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat current knowledge and future challenges . Psychopharmacology. 156:2001;194-215.
36. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry. 52:1995;829-836.
37. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., Pesold C. The phenotypic characteristics of heterozygous reeler mouse. Neuroreport. 10:1999;1329-1334.
38. Waddington J.L., Lane A., Scully P., Meagher D., Quinn J., Larkin C., O'Callaghan E. Early cerebro-craniofacial dysmorphogenesis I schizophrenia a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process . J. Psychiatr. Res. 33:1999;477-489.
39. Willott J.F., Carlson S., Chen H. Prepulse inhibition of the startle response in mice relationship to hearing loss and auditory system plasticity . Behav. Neurosci. 108:1994;1039-1046.
40. Wright, I.K., Crespi, F., Marsden, C.A., Jones, G.H., Robbins, T.W., 1989. Effect of isolation-rearing on 5-HT release in the frontal cortex. J. Neurosci. Methods 29, 283.
41. Yang A.H., Ishii I., Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta. 1582:2002;197-203.